![5'-O-[Bis(4-methoxyphenyl)phenylmethyl]cytidine structure, CAS 112897-99-1](/structures/60000/50714_1_112897_99_1.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 112897-99-1 |
| Catalog No. | 2A-9050714 |
| Chinese Name | 5'-O-[双(4-甲氧基苯基)苯甲基]胞苷 |
| Synonyms | 5'-O-(4,4'-dimethoxytrityl)-cytidine; Uridine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3-methyl; 5'-O-(4,4'-dimethoxytrityl)-3-methyluridine |
| Molecular Formula | C30H31N3O7 |
| Molecular Weight | 545.58 |
| Purity | 98.00 |
| Density | 1.34 |
| Boiling Point | 742.535ºC at 760 mmHg |
| Application | 5′-O-[bis(4-methoxyphenyl)phenylmethyl]cytidine is a purine nucleoside analog. Purine nucleoside analogues have broad antitumor activity and target indolent lymphoid malignancies. The anti-cancer mech |
| SMILES | COc1ccc(C(OCC2OC(n3ccc(N)nc3=O)C(O)C2O)(c2ccccc2)c2ccc(OC)cc2)cc1 |
| InChI Key | SUENBDLQORXVMC-YULOIDQLSA-N |
| MSDS | msds/50714_1_112897_99_1.pdf |
| Transport Info | Product name: 5'-O-[bis(4-methoxyphenyl)phenylmethyl]cytidine |
| Related Products in Biotechnology & Diagnostics | ||
|---|---|---|
| Fmoc-D-Gla(otbu)2-OH | 111662-65-8 | 2A-9050597 |
| 1-Boc-hexahydro-1,4-diazepine | 112275-50-0 | 2A-9050647 |
| N'-Boc-L-lysinamide hydrochloride | 112803-72-2 | 2A-9050682 |
| Fmoc-D-Aspartic acid beta-tert-butyl ester | 112883-39-3 | 2A-9050701 |
| Fmoc-D-Norleucine | 112883-41-7 | 2A-9050703 |
| Boc-D-aspartic acid 4-cyslohexyl ester | 112898-18-7 | 2A-9050715 |
| Boc-L-2-amino-5-phenylpentanoic acid dicyclohexylamine salt | 113756-89-1 | 2A-9050779 |
| 3-Boc-6-oxa-3-aza-bicyclo[3.1.0]hexane | 114214-49-2 | 2A-9050815 |
| 1-Boc-3-hydroxymethylpyrrolidine | 114214-69-6 | 2A-0202117 |
| N-alpha-Fmoc-N-gamma-Boc-D-diaminobutyric acid | 114360-56-4 | 2A-9050820 |
| Browse all Biotechnology & Diagnostics products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA